After Hours
$
75.06
Change
+0.55 +0.74%
Volume
Volume 59,960
May 16, 2022, 6:44 p.m.
Quotes are delayed by 20 min
Previous close
$ 74.90
$ 74.51
Change
-0.39 -0.52%
Day low
Day high
$73.77
$75.00

52 week low
52 week high
$61.91
$88.26

Market cap
$16.50B
Average volume
1.49M
P/E ratio
17.74
Rev. per Employee
$1.49M
EPS
4.20
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on INCY
-
Incyte Corp. stock falls Monday, underperforms market
- MarketWatch Automation
-
Incyte Corp. stock outperforms competitors despite losses on the day
- MarketWatch Automation
-
Incyte Corp. stock outperforms market on strong trading day
- MarketWatch Automation
-
Incyte Corp. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Eli Lilly shares jump 1.7% premarket
- Ciara Linnane
-
FDA approves Eli Lilly and Incyte's Olumiant for treatment of certain hospitalized adults with COVID-19
- Ciara Linnane
-
Incyte Corp. stock outperforms competitors on strong trading day
- MarketWatch Automation
-
Incyte Corp. stock falls Monday, underperforms market
- MarketWatch Automation
-
Incyte Corp. stock underperforms Friday when compared to competitors
- MarketWatch Automation
-
Incyte Corp. stock underperforms Thursday when compared to competitors
- MarketWatch Automation
-
Incyte Corp. stock outperforms market on strong trading day
- MarketWatch Automation
-
Incyte Corp. stock underperforms Tuesday when compared to competitors despite daily gains
- MarketWatch Automation
-
Incyte Corp. stock outperforms market on strong trading day
- MarketWatch Automation
-
Incyte Corp. stock outperforms market despite losses on the day
- MarketWatch Automation
-
Incyte Corp. stock rises Thursday, still underperforms market
- MarketWatch Automation
-
Incyte Corp. stock outperforms market on strong trading day
- MarketWatch Automation
-
Incyte Corp. stock underperforms Tuesday when compared to competitors
- MarketWatch Automation
-
Incyte Corp. stock falls Monday, underperforms market
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
Other News on INCY
-
Was This Acquisition a Smart Move for GlaxoSmithKline?
- Motley Fool
-
Why CTI Biopharma Stock Is Surging Today
- Motley Fool
-
Concert Pharma surges as U.S. patent office upholds key patent
- Seeking Alpha
-
ARKG: Don't Expect Any Favorable Return In Short Or Medium Term
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Incyte Q1 net income drops 17% as operating expenses soar
- Seeking Alpha
-
Incyte Q1 consensus EPS, revenue estimates up Y/Y
- Seeking Alpha
-
Notable earnings before Tuesday's open
- Seeking Alpha
- Loading more headlines...
Earnings Announcement
Press Releases on INCY
-
Incyte to Present at Upcoming Investor Conference
- BusinessWire - BZX
-
3 Top Biotech Stocks To Watch In May 2022
- StockMarket.com
-
Incyte to Report First Quarter Financial Results
- BusinessWire - BZX
-
Incyte to Present at Upcoming Investor Conference
- BusinessWire - BZX
-
- MarketNewsVideo.com
-
- MarketNewsVideo.com
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com